We’re set to receive shares in Danaher’s separated water business. Here’s our plan for the new stock

[ad_1] Danaher (DHR) is a day away from shedding its environmental-and-applied solutions segment, and the Club holding’s ability to deliver returns for shareholders appears stronger than ever. Those potential returns can come from two places: Danaher stock and shares of Veralto (VLTO), the soon-to-be-standalone company that’s in the business of water quality. We see underappreciated…

Read More

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

[ad_1] Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this month, and our plan is to remain invested in the soon-to-be standalone company, known as Veralto, which will trade under the ticker symbol VLTO. That expectation was reinforced Wednesday when Veralto management delivered a presentation for investors and Wall…

Read More

This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher

[ad_1] Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the company’s macular degeneration treatment. If you like this story, sign up for Jim Cramer’s Top 10 Morning Thoughts on the Market email newsletter for free. CNBC’s Jim Cramer said on “Squawk on the Street” that Regeneron…

Read More

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

[ad_1] The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the latest regulatory filings from influential Wall Street pros. These big-name investors also made moves in nine other Club stocks during a strong three-month stretch that ended the best first half for the market in years. Starting with Salesforce,…

Read More